Par Drugs And Chemicals Limited has informed the Exchange about Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals Limited has submitted a compliance certificate to the exchange as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025. This certificate, typically issued by the company's Registrar and Share Transfer Agent (RTA), confirms the details of physical shares that were dematerialized or rematerialized during the quarter. It is a routine regulatory filing mandated for all listed companies to ensure proper reconciliation of shareholding records between the company, RTA, and depositories. No specific financial numbers, share counts, or anomalies have been disclosed in the filing headline.
This is a routine procedural compliance filing with no material impact on the company's financials or stock price. It simply confirms adherence to SEBI's depository regulations for the January–March 2025 quarter.